[go: up one dir, main page]

AU3735793A - Retroviral protease inhibitors - Google Patents

Retroviral protease inhibitors

Info

Publication number
AU3735793A
AU3735793A AU37357/93A AU3735793A AU3735793A AU 3735793 A AU3735793 A AU 3735793A AU 37357/93 A AU37357/93 A AU 37357/93A AU 3735793 A AU3735793 A AU 3735793A AU 3735793 A AU3735793 A AU 3735793A
Authority
AU
Australia
Prior art keywords
protease inhibitors
retroviral protease
retroviral
inhibitors
protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37357/93A
Inventor
Geoffrey Bainbridge Dreyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU3735793A publication Critical patent/AU3735793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37357/93A 1992-02-26 1993-02-26 Retroviral protease inhibitors Abandoned AU3735793A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US842295 1986-03-26
US84229592A 1992-02-26 1992-02-26
US84229992A 1992-02-26 1992-02-26
US842299 1992-02-26

Publications (1)

Publication Number Publication Date
AU3735793A true AU3735793A (en) 1993-09-13

Family

ID=27126334

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37357/93A Abandoned AU3735793A (en) 1992-02-26 1993-02-26 Retroviral protease inhibitors

Country Status (4)

Country Link
EP (1) EP0628035A4 (en)
JP (1) JPH07504417A (en)
AU (1) AU3735793A (en)
WO (1) WO1993017003A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA49803C2 (en) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко METHOD FOR TREATMENT OF RETROVIRAL INFECTIONS
WO1998038167A1 (en) * 1997-02-26 1998-09-03 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
AP2002002595A0 (en) * 2000-02-04 2002-09-30 Pfizer Prod Inc Heterocyclic amide derivatives.
DE60124080T2 (en) 2000-03-23 2007-03-01 Elan Pharmaceuticals, Inc., San Francisco COMPOUNDS AND METHOD FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MXPA02012560A (en) 2000-06-30 2003-05-14 Elan Pharm Inc Compounds to treat alzheimer s disease.
US6846813B2 (en) 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
PE20020276A1 (en) 2000-06-30 2002-04-06 Elan Pharm Inc SUBSTITUTE AMINE COMPOUNDS AS ß-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER
US6982264B2 (en) 2001-06-27 2006-01-03 Elan Pharmaceuticals, Inc. Substituted alcohols useful in treatment of Alzheimer's disease
IL309732A (en) 2021-07-09 2024-02-01 Aligos Therapeutics Inc Anti-viral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997551A (en) * 1970-12-30 1976-12-14 Argus Chemical Corporation 3-Salicylamido-s-triazoles
US4038406A (en) * 1972-09-26 1977-07-26 Bayer Aktiengesellschaft 1,2,4-triazole antimycotic compositions and use thereof
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols

Also Published As

Publication number Publication date
JPH07504417A (en) 1995-05-18
WO1993017003A1 (en) 1993-09-02
EP0628035A4 (en) 1995-03-29
EP0628035A1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
AU3566089A (en) Retroviral protease inhibitors
AU5533094A (en) Enzyme inhibitors
KR100190517B1 (en) Hiv protease inhibitors
HU9302080D0 (en) Amine-diole protease inhibitors
ZA915269B (en) Retroviral protease inhibitors
AU5208193A (en) Guanidinyl-substituted heterocyclic thrombin inhibitors
HU9601508D0 (en) Dp-iv-serine protease inhibitors
IL102534A0 (en) Retroviral protease inhibitors
AU9122391A (en) Hiv protease inhibitors
AU5069993A (en) Retroviral protease inhibitors
AU4678489A (en) Retroviral protease inhibitors
AU7963394A (en) Mercaptosulfide metalloproteinase inhibitors
AU8320691A (en) Inhibitors of retroviral proteases
AU8994191A (en) Retroviral protease inhibitors derived from 3-chloro-2- chloromethyl-1-propene
AU3735793A (en) Retroviral protease inhibitors
AU7518694A (en) Retroviral protease inhibitors and combinations thereof
AUPM982594A0 (en) HIV protease inhibitors
AU6828894A (en) Hiv protease inhibitors
AU7132391A (en) Hiv protease inhibitors
EP0566237A3 (en) Retroviral protease inhibitors.
IL105450A0 (en) Hydroxy-carbamate retroviral protease inhibitors
HK1014508A (en) Dp-iv-serine protease inhibitors
AU1739792A (en) Novel thrombin inhibitors
HK1008334A (en) Hiv protease inhibitors
ZA925360B (en) Retroviral protease inhibitors.